ASGCT President Terry Flotte Touts Rare Disease Initiatives as His Term Ends

Terry Flotte, MD, steps down as ASGCT president at the end of this week. In this exclusive interview, Terry shares the highlights of his tenure, including important initiatives in expanding access to cell and gene therapies for rare and ultra-rare diseases. The post ASGCT President Terry Flotte Touts Rare Disease Initiatives as His Term Ends appeared first on GEN - Genetic Engineering and Biotechnology News .